EXECUTIVE ENGAGEMENTS
OUTREACH
2183
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
393
Interactions with Platform & by Email
PARTICIPANTS
66
Unique # Participated
VALIDATIONS
31
Responses Validated*
COMPETITORS
47
Responses Validated*
BRANDS
102
Responses Validated*
* Login for a full stack data experience
DATE
SEP 2020
TABLES
108
PAGES
185
EDITION
19
PRICE
USD $5600
HIGHLIGHTS
Amid the COVID-19 crisis, the global market for Mesenchymal Stem Cells (MSC) estimated at US$172.9 Million in the year 2020, is projected to reach a revised size of US$229 Million by 2027, growing at a CAGR of 4.1% over the analysis period 2020-2027. Human MSC, one of the segments analyzed in the report, is projected to record a 4.6% CAGR and reach US$94.8 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Mouse MSC segment is readjusted to a revised 4% CAGR for the next 7-year period.
The Mesenchymal Stem Cells (MSC) market in the U.S. is estimated at US$50.9 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$40.6 Million by the year 2027 trailing a CAGR of 3.9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.8% and 3.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.
In the global Rat MSC segment, USA, Canada, Japan, China and Europe will drive the 3.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$27.7 Million in the year 2020 will reach a projected size of US$36.2 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$25.5 Million by the year 2027.
SELECT PLAYERS
Cell Applications Inc.; Celprogen Inc.; Cyagen US Inc.; Genlantis Inc.; Lonza Group; Mesoblast Limited; MilliporeSigma; Neuromics; Orthofix International N.V.; PromoCell GmbH; R&D Systems Inc.; ScienCell Research Laboratories; Stemcell Technologies Inc.; Stemedica Cell Technologies Inc.; Thermo Fischer Scientific Inc.
SEGMENTS
» Type (Human MSC, Mouse MSC, Rat MSC, Other Types) » Application (Research Institutes, Hospitals, Other Applications)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
TABLE OF CONTENTS
| I. INTRODUCTION, METHODOLOGY & REPORT SCOPE |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Mesenchymal Stem Cells Market on a Rapid Growth Path |
| Recent Market Activity |
| Current and Future Analysis |
| The Present and Future of MSC Therapies |
| Select MSC-based Therapeutics |
| Mesenchymal Stem Cell Research |
| Completed Phase III Studies with MSCs |
| MSCs are Being Explored for Several New Treatment Possibilities |
| Widespread Commercialization of 'Off-the-Shelf' MSCs to Become a Reality |
| Software Companies Endeavour to Cash in on the Boom |
| Global Competitor Market Shares |
| Mesenchymal Stem Cells (MSC) Competitor Market Share Scenario Worldwide (in %): 2018 & 2029 |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| Cell Applications, Inc. (USA) |
| Celprogen, Inc. (USA) |
| Cyagen US Inc. (USA) |
| Genlantis, Inc. (USA) |
| Lonza Group (Switzerland) |
| Mesoblast Limited (Australia) |
| MilliporeSigma (USA) |
| Neuromics (USA) |
| Orthofix International N.V. (Italy) |
| PromoCell GmbH (Germany) |
| R&D Systems, Inc. (USA) |
| ScienCell Research Laboratories (USA) |
| Stemcell Technologies Inc. (Canada) |
| Stemedica Cell Technologies, Inc. (USA) |
| Thermo Fischer Scientific, Inc. (USA) |
| Vitro Biopharma (USA) |
| 3. MARKET TRENDS & DRIVERS |
| Development of Regenerative Medicine Accelerates Demand for MSCs |
| Ageing Demographics to Drive Demand for Mesenchymal Stem Cell Therapies |
| Global Aging Population Statistics - Opportunity Indicators |
| Growing Prevalence of Chronic Diseases Propels Demand for Mesenchymal Stem Cells |
| Key Disease Statistics - Opportunity Indicators |
| Growing Volume of Orthopedic Procedures: An Opportunity for the MSC Market |
| Adult Stem Cell Therapies on Growth Trajectory, as Controversies Continue to Haunt Embryonic Stem Cell Research |
| Adult Stem Cells and Embryonic Stem Cells - A Comparison |
| MSCs Versus Embryonic or Induced Pluripotent Stem Cells |
| MSC Therapies - Immune to Ethical Issues Applicable to Embryonic Stem Cells |
| MSCs - A Potential Vehicle for 'Targeted Drug Delivery' |
| Stem Cell Based Bone Grafts: Promising Growth Ahead |
| Loopholes Associated with In Vivo Properties Constrain Therapeutic Advancements |
| Major Challenges Confronting Mesenchymal Stem Cell Market |
| Allogeneic MSCs - Offering Promise in Immunosuppressive and Tissue Repair Therapy |
| Administration Route Determines the Effectiveness of MSCs |
| 4. GLOBAL MARKET PERSPECTIVE |
| Mesenchymal Stem Cells (MSC) Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018-2025 |
| Mesenchymal Stem Cells (MSC) Global Retrospective Market Scenario in US$ Thousand by Region/Country: 2009-2017 |
| Mesenchymal Stem Cells (MSC) Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025 |
| Human MSC (Type) World Market by Region/Country in US$ Thousand: 2018 to 2025 |
| Human MSC (Type) Historic Market Analysis by Region/Country in US$ Thousand: 2009 to 2017 |
| Human MSC (Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025 |
| Mouse MSC (Type) Potential Growth Markets Worldwide in US$ Thousand: 2018 to 2025 |
| Mouse MSC (Type) Historic Market Perspective by Region/Country in US$ Thousand: 2009 to 2017 |
| Mouse MSC (Type) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025 |
| Rat MSC (Type) Geographic Market Spread Worldwide in US$ Thousand: 2018 to 2025 |
| Rat MSC (Type) Region Wise Breakdown of Global Historic Demand in US$ Thousand: 2009 to 2017 |
| Rat MSC (Type) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025 |
| Other Types (Type) World Market Estimates and Forecasts by Region/Country in US$ Thousand: 2018 to 2025 |
| Other Types (Type) Market Historic Review by Region/Country in US$ Thousand: 2009 to 2017 |
| Other Types (Type) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025 |
| Research Institutes (Application) Worldwide Latent Demand Forecasts in US$ Thousand by Region/Country: 2018-2025 |
| Research Institutes (Application) Global Historic Analysis in US$ Thousand by Region/Country: 2009-2017 |
| Research Institutes (Application) Distribution of Global Sales by Region/Country: 2009 VS 2019 VS 2025 |
| Hospitals (Application) Sales Estimates and Forecasts in US$ Thousand by Region/Country for the Years 2018 through 2025 |
| Hospitals (Application) Analysis of Historic Sales in US$ Thousand by Region/Country for the Years 2009 to 2017 |
| Hospitals (Application) Global Market Share Distribution by Region/Country for 2009, 2019, and 2025 |
| Other Applications (Application) Global Opportunity Assessment in US$ Thousand by Region/Country: 2018-2025 |
| Other Applications (Application) Historic Sales Analysis in US$ Thousand by Region/Country: 2009-2017 |
| Other Applications (Application) Percentage Share Breakdown of Global Sales by Region/Country: 2009 VS 2019 VS 2025 |
| III. MARKET ANALYSIS |
| GEOGRAPHIC MARKET ANALYSIS |
| United States |
| Market Facts & Figures |
| US Mesenchymal Stem Cells (MSC) Market Share (in %) by Company: 2018 & 2025 |
| United States Mesenchymal Stem Cells (MSC) Market Estimates and Projections in US$ Thousand by Type: 2018 to 2025 |
| Mesenchymal Stem Cells (MSC) Market in the United States by Type: A Historic Review in US$ Thousand for 2009-2017 |
| United States Mesenchymal Stem Cells (MSC) Market Share Breakdown by Type: 2009 VS 2019 VS 2025 |
| United States Mesenchymal Stem Cells (MSC) Latent Demand Forecasts in US$ Thousand by Application: 2018 to 2025 |
| Mesenchymal Stem Cells (MSC) Historic Demand Patterns in the United States by Application in US$ Thousand for 2009-2017 |
| Mesenchymal Stem Cells (MSC) Market Share Breakdown in the United States by Application: 2009 VS 2019 VS 2025 |
| Canada |
| Canadian Mesenchymal Stem Cells (MSC) Market Estimates and Forecasts in US$ Thousand by Type: 2018 to 2025 |
| Canadian Mesenchymal Stem Cells (MSC) Historic Market Review by Type in US$ Thousand: 2009-2017 |
| Mesenchymal Stem Cells (MSC) Market in Canada: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025 |
| Canadian Mesenchymal Stem Cells (MSC) Market Quantitative Demand Analysis in US$ Thousand by Application: 2018 to 2025 |
| Mesenchymal Stem Cells (MSC) Market in Canada: Summarization of Historic Demand Patterns in US$ Thousand by Application for 2009-2017 |
| Canadian Mesenchymal Stem Cells (MSC) Market Share Analysis by Application: 2009 VS 2019 VS 2025 |
| Japan |
| Japanese Market for Mesenchymal Stem Cells (MSC): Annual Sales Estimates and Projections in US$ Thousand by Type for the Period 2018-2025 |
| Mesenchymal Stem Cells (MSC) Market in Japan: Historic Sales Analysis in US$ Thousand by Type for the Period 2009-2017 |
| Japanese Mesenchymal Stem Cells (MSC) Market Share Analysis by Type: 2009 VS 2019 VS 2025 |
| Japanese Demand Estimates and Forecasts for Mesenchymal Stem Cells (MSC) in US$ Thousand by Application: 2018 to 2025 |
| Japanese Mesenchymal Stem Cells (MSC) Market in US$ Thousand by Application: 2009-2017 |
| Mesenchymal Stem Cells (MSC) Market Share Shift in Japan by Application: 2009 VS 2019 VS 2025 |
| China |
| Chinese Mesenchymal Stem Cells (MSC) Market Growth Prospects in US$ Thousand by Type for the Period 2018-2025 |
| Mesenchymal Stem Cells (MSC) Historic Market Analysis in China in US$ Thousand by Type: 2009-2017 |
| Chinese Mesenchymal Stem Cells (MSC) Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
| Chinese Demand for Mesenchymal Stem Cells (MSC) in US$ Thousand by Application: 2018 to 2025 |
| Mesenchymal Stem Cells (MSC) Market Review in China in US$ Thousand by Application: 2009-2017 |
| Chinese Mesenchymal Stem Cells (MSC) Market Share Breakdown by Application: 2009 VS 2019 VS 2025 |
| Europe |
| Market Facts & Figures |
| European Mesenchymal Stem Cells (MSC) Market: Competitor Market Share Scenario (in %) for 2018 & 2025 |
| European Mesenchymal Stem Cells (MSC) Market Demand Scenario in US$ Thousand by Region/Country: 2018-2025 |
| Mesenchymal Stem Cells (MSC) Market in Europe: A Historic Market Perspective in US$ Thousand by Region/Country for the Period 2009-2017 |
| European Mesenchymal Stem Cells (MSC) Market Share Shift by Region/Country: 2009 VS 2019 VS 2025 |
| European Mesenchymal Stem Cells (MSC) Market Estimates and Forecasts in US$ Thousand by Type: 2018-2025 |
| Mesenchymal Stem Cells (MSC) Market in Europe in US$ Thousand by Type: A Historic Review for the Period 2009-2017 |
| European Mesenchymal Stem Cells (MSC) Market Share Breakdown by Type: 2009 VS 2019 VS 2025 |
| European Mesenchymal Stem Cells (MSC) Addressable Market Opportunity in US$ Thousand by Application: 2018-2025 |
| Mesenchymal Stem Cells (MSC) Market in Europe: Summarization of Historic Demand in US$ Thousand by Application for the Period 2009-2017 |
| European Mesenchymal Stem Cells (MSC) Market Share Analysis by Application: 2009 VS 2019 VS 2025 |
| France |
| Mesenchymal Stem Cells (MSC) Market in France by Type: Estimates and Projections in US$ Thousand for the Period 2018-2025 |
| French Mesenchymal Stem Cells (MSC) Historic Market Scenario in US$ Thousand by Type: 2009-2017 |
| French Mesenchymal Stem Cells (MSC) Market Share Analysis by Type: 2009 VS 2019 VS 2025 |
| Mesenchymal Stem Cells (MSC) Quantitative Demand Analysis in France in US$ Thousand by Application: 2018-2025 |
| French Mesenchymal Stem Cells (MSC) Historic Market Review in US$ Thousand by Application: 2009-2017 |
| French Mesenchymal Stem Cells (MSC) Market Share Analysis: A 17-Year Perspective by Application for 2009, 2019, and 2025 |
| Germany |
| Mesenchymal Stem Cells (MSC) Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Type for the Period 2018-2025 |
| German Mesenchymal Stem Cells (MSC) Historic Market Analysis in US$ Thousand by Type: 2009-2017 |
| German Mesenchymal Stem Cells (MSC) Market Share Breakdown by Type: 2009 VS 2019 VS 2025 |
| Mesenchymal Stem Cells (MSC) Market in Germany: Annual Sales Estimates and Forecasts in US$ Thousand by Application for the Period 2018-2025 |
| German Mesenchymal Stem Cells (MSC) Market in Retrospect in US$ Thousand by Application: 2009-2017 |
| Mesenchymal Stem Cells (MSC) Market Share Distribution in Germany by Application: 2009 VS 2019 VS 2025 |
| Italy |
| Italian Mesenchymal Stem Cells (MSC) Market Growth Prospects in US$ Thousand by Type for the Period 2018-2025 |
| Mesenchymal Stem Cells (MSC) Historic Market Analysis in Italy in US$ Thousand by Type: 2009-2017 |
| Italian Mesenchymal Stem Cells (MSC) Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
| Italian Demand for Mesenchymal Stem Cells (MSC) in US$ Thousand by Application: 2018 to 2025 |
| Mesenchymal Stem Cells (MSC) Market Review in Italy in US$ Thousand by Application: 2009-2017 |
| Italian Mesenchymal Stem Cells (MSC) Market Share Breakdown by Application: 2009 VS 2019 VS 2025 |
| United Kingdom |
| United Kingdom Market for Mesenchymal Stem Cells (MSC): Annual Sales Estimates and Projections in US$ Thousand by Type for the Period 2018-2025 |
| Mesenchymal Stem Cells (MSC) Market in the United Kingdom: Historic Sales Analysis in US$ Thousand by Type for the Period 2009-2017 |
| United Kingdom Mesenchymal Stem Cells (MSC) Market Share Analysis by Type: 2009 VS 2019 VS 2025 |
| United Kingdom Demand Estimates and Forecasts for Mesenchymal Stem Cells (MSC) in US$ Thousand by Application: 2018 to 2025 |
| United Kingdom Mesenchymal Stem Cells (MSC) Market in US$ Thousand by Application: 2009-2017 |
| Mesenchymal Stem Cells (MSC) Market Share Shift in the United Kingdom by Application: 2009 VS 2019 VS 2025 |
| Rest of Europe |
| Rest of Europe Mesenchymal Stem Cells (MSC) Market Estimates and Forecasts in US$ Thousand by Type: 2018-2025 |
| Mesenchymal Stem Cells (MSC) Market in Rest of Europe in US$ Thousand by Type: A Historic Review for the Period 2009-2017 |
| Rest of Europe Mesenchymal Stem Cells (MSC) Market Share Breakdown by Type: 2009 VS 2019 VS 2025 |
| Rest of Europe Mesenchymal Stem Cells (MSC) Addressable Market Opportunity in US$ Thousand by Application: 2018-2025 |
| Mesenchymal Stem Cells (MSC) Market in Rest of Europe: Summarization of Historic Demand in US$ Thousand by Application for the Period 2009-2017 |
| Rest of Europe Mesenchymal Stem Cells (MSC) Market Share Analysis by Application: 2009 VS 2019 VS 2025 |
| Asia-Pacific |
| Mesenchymal Stem Cells (MSC) Market in Asia-Pacific by Type: Estimates and Projections in US$ Thousand for the Period 2018-2025 |
| Asia-Pacific Mesenchymal Stem Cells (MSC) Historic Market Scenario in US$ Thousand by Type: 2009-2017 |
| Asia-Pacific Mesenchymal Stem Cells (MSC) Market Share Analysis by Type: 2009 VS 2019 VS 2025 |
| Mesenchymal Stem Cells (MSC) Quantitative Demand Analysis in Asia-Pacific in US$ Thousand by Application: 2018-2025 |
| Asia-Pacific Mesenchymal Stem Cells (MSC) Historic Market Review in US$ Thousand by Application: 2009-2017 |
| Asia-Pacific Mesenchymal Stem Cells (MSC) Market Share Analysis: A 17-Year Perspective by Application for 2009, 2019, and 2025 |
| Rest of World |
| Rest of World Mesenchymal Stem Cells (MSC) Market Estimates and Forecasts in US$ Thousand by Type: 2018 to 2025 |
| Rest of World Mesenchymal Stem Cells (MSC) Historic Market Review by Type in US$ Thousand: 2009-2017 |
| Mesenchymal Stem Cells (MSC) Market in Rest of World: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025 |
| Rest of World Mesenchymal Stem Cells (MSC) Market Quantitative Demand Analysis in US$ Thousand by Application: 2018 to 2025 |
| Mesenchymal Stem Cells (MSC) Market in Rest of World: Summarization of Historic Demand Patterns in US$ Thousand by Application for 2009-2017 |
| Rest of World Mesenchymal Stem Cells (MSC) Market Share Analysis by Application: 2009 VS 2019 VS 2025 |
| IV. COMPETITION |
| Total Companies Profiled: 47 |
